Literature DB >> 28163488

Ameloblastic fibroodontoma or complex odontoma: Two faces of the same coin.

Akhilesh Kumar Singh1, Indu Bhusan Kar2, Niranjan Mishra2, Parikshit Sharma3.   

Abstract

An ameloblastic fibroodontoma (AFO) is a rare odontogenic tumor of mixed dental tissue origin. It exhibits histological features of ameloblastic fibroma and complex odontoma. AFOs are usually found to be asymptomatic and are most often discovered on routine radiography. Sometimes their presence is suspected due to missing permanent dentition. We report a case of an 18-year-old female patient with missing mandibular molars on the left side associated with a giant complex odontoma. Treatment included surgical excision of the tumor followed by reconstruction with iliac crest graft. Histopathological study revealed it as an AFO, to our surprise.

Entities:  

Keywords:  Ameloblastic fibroodontoma; complex odontoma; mandible; odontogenic tumor

Year:  2016        PMID: 28163488      PMCID: PMC5242084          DOI: 10.4103/0975-5950.196129

Source DB:  PubMed          Journal:  Natl J Maxillofac Surg        ISSN: 0975-5950


  5 in total

1.  Ameloblastic fibro-odontoma: a case report.

Authors:  Hyunho Chang; David S Precious; Michael S Shimizu
Journal:  J Can Dent Assoc       Date:  2002-04       Impact factor: 1.316

2.  The mixed odontogenic tumors.

Authors:  D G Gardner
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1984-08

3.  An analysis of the interrelationship of the mixed odontogenic tumors--ameloblastic fibroma, ameloblastic fibro-odontoma, and the odontomas.

Authors:  P J Slootweg
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1981-03

4.  Malignant transformation of ameloblastic fibro-odontoma to ameloblastic fibrosarcoma.

Authors:  R M Howell; E J Burkes
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1977-03

5.  Ameloblastic fibroma, ameloblastic fibro-odontoma, and odontoma.

Authors:  Donald M Cohen; Indraneel Bhattacharyya
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2004-08       Impact factor: 2.802

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.